Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Shares Gap Up – What’s Next?

Shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) gapped up prior to trading on Monday . The stock had previously closed at $15.76, but opened at $16.68. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $16.68, with a volume of 375 shares changing hands.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on TLX shares. UBS Group started coverage on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Friday, November 15th. They issued a “buy” rating and a $21.00 price objective on the stock. William Blair raised shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research report on Tuesday, November 19th.

Telix Pharmaceuticals Limited American Depositary Shares Trading Up 0.1 %

About Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.